Fourteen companies join EuropaBio
Advertisement
Fourteen companies join EuropaBio, increasing the industry's membership base and representation in Europe. "Important issues in the agro, industrial and healthcare sectors still remain in Europe, so having the sector well represented in Brussels means the industry can actively contribute to the political environment and help convince policy makers to build the bio-economy," says Feike Sijbesma, Chairman of EuropaBio, the EU association for bioindustries. "It is important too to give feedback to policy makers on what the European biotech industry thinks about issues and rules. The diversity of the new organisations joining EuropaBio will strengthen the association and add to its already extensive network."
The small and medium sized companies joining EuropaBio come from different industry sectors that are using biotechnology. Some are making plastics, others are producing medicines to meet unmet medical needs for the developing and developed parts of the world. A new Regional cluster brings with them leading edge new emerging biotech companies. An end to Europe's cluttered events calendar for biotech companies might also be in sight with the introduction of events organisers to the association as associate members. This gives events organisers a platform to work together, agree the calendar and directly work with the industry.
EuropaBio's new members are Bioton S.A., Crucell N.V., CSM / Purac, MorphoSys AG, PamGene, Rottapharm, National Association and Barabas Zoltan Federation of Biotechnology. As Associate Members, EuropaBio also welcomes Consilium and FlandersBio.
Other news from the department business & finance
